The IL-17 signaling pathway indirectly triggers the release of proinflammatory cytokines, including TNF and IL-6 [49], which subsequently activate the NF-κB pathway, thereby exacerbating inflammatory liver diseases and related pathological conditions [50]. Here, IL17A is linked to liver disorder.